XML 83 R73.htm IDEA: XBRL DOCUMENT v3.25.1
Stockholders’ Equity (Details)
 3 Months Ended
Mar. 31, 2025
USD ($)
vote
$ / shares
shares
Mar. 31, 2024
shares
Dec. 31, 2024
$ / shares
shares
Sep. 30, 2022
USD ($)
Schedule of the Effects of the Tender Offer Repurchase Price Over the Estimated Fair Value of the Common Stock Redeemed [Line Items]        
Preferred stock, shares authorized (in shares) 25,000,000   25,000,000  
Preferred stock, shares issued (in shares) 0   0  
Preferred stock, shares outstanding (in shares) 0   0  
Common stock, shares authorized (in shares) 500,000,000   500,000,000  
Common stock, par value (in USD per share) | $ / shares $ 0.001   $ 0.001  
Shares issued (in shares) 69,587,834   64,043,799  
Shares outstanding (in shares) 69,587,834   64,043,799  
Stockholders vote | vote 1      
Dividends | $ $ 0      
Share Repurchase Plan        
Schedule of the Effects of the Tender Offer Repurchase Price Over the Estimated Fair Value of the Common Stock Redeemed [Line Items]        
Share repurchase plan, authorized amount | $       $ 40,000,000
Treasury stock, shares, acquired (in shares) 1,103,601      
Treasury stock, shares, retired (in shares) 1,103,601      
Treasury stock, value, acquired, cost method | $ $ 5,000,000.0      
Treasury stock, retired, cost method, amount | $ $ 5,000,000.0      
Treasury stock acquired, average cost per share (in USD per share) | $ / shares $ 4.51      
Repurchase of common stock (in shares)   0    
Stock repurchase program, remaining authorized repurchase amount | $ $ 24,800,000      
Vitalware L L C | Able Health Inc        
Schedule of the Effects of the Tender Offer Repurchase Price Over the Estimated Fair Value of the Common Stock Redeemed [Line Items]        
Shares issued (in shares) 106,196      
Shares outstanding (in shares) 106,196